Producing SARS-CoV-2’s RaTG13-like backbone with a pangolin-like RBD by natural recombination would require a RaTG13-like and a pangolin-like virus co-infecting one cell in one host simultaneously - improbable given low pangolin population density, the scarcity of these CoVs in pangolins, and that reconstituted RaTG13 does not bind pangolin ACE2 - so an engineered chimera is a competitive explanation.

Reasoning

Natural recombination requires two divergent parental viruses to be present in the same cell of the same animal at the same time. For a RaTG13-like backbone to recombine with a pangolin-CoV RBD, a host (e.g. a pangolin) would need co-infection by both lineages. The authors argue this is unlikely because pangolins occur at low population density and rarely carry these coronaviruses, and - critically - receptor-binding studies show reconstituted RaTG13 does not bind pangolin ACE2, so a RaTG13-like virus is unlikely to have productively infected a pangolin to meet the pangolin CoV in the first place. If the single natural-recombination route is improbable, then deliberate laboratory recombination - trivial to perform and leaving the same chimeric signature - becomes a competitive explanation for the observed backbone/RBD split.

Validity verdict — approved (checked)

Reconstruction. Premises: (i) natural recombination requires two divergent parents co-infecting one cell of one host; (ii) for a RaTG13-like backbone + pangolin-CoV RBD this venue is a pangolin, which is low-density and rarely carries these CoVs; (iii) reconstituted RaTG13 does not bind pangolin ACE2, so a RaTG13-like virus is unlikely to have productively infected a pangolin; (iv) lab recombination is trivial and leaves the same chimeric signature. Load-bearing step: from “the pangolin-mediated natural recombination route is improbable” to “an engineered chimera is a competitive explanation.”

Evaluation. This is a comparative-likelihood move: if P(observed chimeric structure | natural) is depressed while P(observed | engineered) is not, the likelihood ratio lifts the lab hypothesis to “competitive.” Conditional on the premises the step is valid, and the conclusion is suitably weak (“competitive,” not “confirmed”), so no completion-by-force. Note the argument carries an implicit premise that the recombination venue must be a pangolin (the receptor argument only bites for pangolin as host); a recombination in a third host, or the finding that the RBD actually nests in the wild BANAL bat clade (see A-66), would undercut premise (ii)-(iii). But those bear on the truth of the “natural route is improbable” premise, priced at step 8 — not on the inferential step, which holds given the premises. Approved; traced here → checked.